Svitinib 50 Capsule
By Svitinib
Rx
7 Capsule in a Strip

Composition
Sunitinib(50mg)

Manufacturer - Mylan Pharmaceuticals Pvt Ltd
Mylan Pharmaceuticals Private Limited , Commercial Operations , Prestige Tech Park,Platina-3, 7th to 12th floor, Prestige Tech Park, Kadubesanahalli, Bangalore -560103

Expires on or after
July, 2025

liver
Svitinib 50 Capsule is considered safe for use in patients with liver disease, and it does not require any dose adjustment. This means that individuals with liver issues can generally take Svitinib 50 Capsule without specific concerns about their liver condition impacting the dosage.

kidney
Svitinib 50 Capsule is safe for patients with kidney disease. No dose adjustment is needed for this medication.

alcohol
Consult your doctor when consuming alcohol with Svitinib 50 Capsule.

driving
During Svitinib 50 Capsule treatment, be cautious as it may cause dizziness, affecting your ability to drive or operate machinery. If you experience dizziness, avoid driving.

pregnancy
Svitinib 50 Capsule may not be safe during pregnancy as animal studies suggest potential harm to the developing baby. Your doctor will evaluate the benefits and risks before prescribing it. Please consult your doctor before using this medication during pregnancy.

breastfeeding
Svitinib 50 Capsule is likely unsafe for breastfeeding mothers. Limited data indicates the drug might transfer to breastmilk and cause harm to the baby.
Habit Forming | No |
Chemical Class | Indole and Pyrrole Derivative |
Therapeutic Class | - |
Action Class | - |
₹2050
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024